JPS52151183A - Phenylpyperazine - Google Patents

Phenylpyperazine

Info

Publication number
JPS52151183A
JPS52151183A JP4727677A JP4727677A JPS52151183A JP S52151183 A JPS52151183 A JP S52151183A JP 4727677 A JP4727677 A JP 4727677A JP 4727677 A JP4727677 A JP 4727677A JP S52151183 A JPS52151183 A JP S52151183A
Authority
JP
Japan
Prior art keywords
phenylpyperazine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4727677A
Other languages
English (en)
Japanese (ja)
Inventor
Pomufuretsudo Buaaji Jiyon
Bofuii Jiyamison Uiriamu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lilly Industries Ltd
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Publication of JPS52151183A publication Critical patent/JPS52151183A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/42—Singly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP4727677A 1976-04-23 1977-04-23 Phenylpyperazine Pending JPS52151183A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB16526/76A GB1575904A (en) 1976-04-23 1976-04-23 Phenyl piperazines

Publications (1)

Publication Number Publication Date
JPS52151183A true JPS52151183A (en) 1977-12-15

Family

ID=10078930

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4727677A Pending JPS52151183A (en) 1976-04-23 1977-04-23 Phenylpyperazine

Country Status (34)

Country Link
JP (1) JPS52151183A (fr)
AR (2) AR222003A1 (fr)
AT (1) AT355579B (fr)
AU (1) AU514822B2 (fr)
BE (1) BE853899A (fr)
BG (2) BG28055A3 (fr)
CA (1) CA1087617A (fr)
CH (2) CH633009A5 (fr)
CS (1) CS196360B2 (fr)
DD (1) DD129790A5 (fr)
DE (1) DE2717415A1 (fr)
DK (1) DK176177A (fr)
ES (2) ES457988A1 (fr)
FI (1) FI63937C (fr)
FR (1) FR2348925A1 (fr)
GB (1) GB1575904A (fr)
GR (1) GR64084B (fr)
HU (1) HU176820B (fr)
IE (1) IE44730B1 (fr)
IL (1) IL51787A (fr)
LU (1) LU77170A1 (fr)
MX (1) MX4596E (fr)
NL (1) NL7704456A (fr)
NO (1) NO146710C (fr)
NZ (1) NZ183715A (fr)
OA (1) OA05643A (fr)
PH (1) PH14124A (fr)
PL (1) PL117466B1 (fr)
PT (1) PT66452B (fr)
RO (1) RO72831A (fr)
SE (1) SE7704536L (fr)
SU (2) SU664564A3 (fr)
YU (1) YU104477A (fr)
ZA (1) ZA771849B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0657442A2 (fr) 1993-12-02 1995-06-14 Asahi Chemical Co., Ltd. Dérivés de thiazole, procédé de préparation et leur utilisation

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1601310A (en) * 1978-05-23 1981-10-28 Lilly Industries Ltd Aryl hydantoins
DE3142608A1 (de) * 1981-10-28 1983-05-05 Basf Ag, 6700 Ludwigshafen Polyazofarbstoffe
US5834499A (en) * 1994-03-11 1998-11-10 Yamanouchi Pharmaceutical Co., Ltd. 5-HT3 receptor agonist, novel thiazole derivative and intermediate thereof
CA2144669A1 (fr) * 1994-03-29 1995-09-30 Kozo Akasaka Derives du biphenyle
GB9517381D0 (en) * 1995-08-24 1995-10-25 Pharmacia Spa Aryl and heteroaryl piperazine derivatives
DZ3292A1 (fr) * 2001-09-13 2005-05-14 Solvay Pharm Gmbh Nouveaux composes de type 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]piperazine, methodes pour les preparer et medicaments renfermant cescomposes
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
US7829713B2 (en) * 2006-02-28 2010-11-09 Helicon Therapeutics, Inc. Therapeutic piperazines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0657442A2 (fr) 1993-12-02 1995-06-14 Asahi Chemical Co., Ltd. Dérivés de thiazole, procédé de préparation et leur utilisation

Also Published As

Publication number Publication date
DK176177A (da) 1977-10-24
NO146710C (no) 1982-11-24
SU727146A3 (ru) 1980-04-05
ZA771849B (en) 1978-11-29
CA1087617A (fr) 1980-10-14
PL117466B1 (en) 1981-08-31
CH633009A5 (en) 1982-11-15
FI771287A7 (fr) 1977-10-24
ES467948A1 (es) 1978-11-01
RO72831B (ro) 1983-07-30
AT355579B (de) 1980-03-10
PT66452A (en) 1977-05-01
FI63937B (fi) 1983-05-31
FR2348925B1 (fr) 1980-04-11
IL51787A (en) 1980-02-29
SU664564A3 (ru) 1979-05-25
LU77170A1 (fr) 1979-01-18
NO146710B (no) 1982-08-16
YU104477A (en) 1983-01-21
OA05643A (fr) 1981-04-30
CH625802A5 (en) 1981-10-15
BG28055A3 (bg) 1980-02-25
HU176820B (en) 1981-05-28
NL7704456A (nl) 1977-10-25
PH14124A (en) 1981-02-26
PL197550A1 (pl) 1979-05-21
MX4596E (es) 1982-06-25
FI63937C (fi) 1983-09-12
DD129790A5 (de) 1978-02-08
SE7704536L (sv) 1977-10-24
PT66452B (en) 1979-03-09
AR222635A1 (es) 1981-06-15
BE853899A (fr) 1977-10-24
GR64084B (en) 1980-01-21
CS196360B2 (en) 1980-03-31
ES457988A1 (es) 1978-07-16
NZ183715A (en) 1980-04-28
AU2438677A (en) 1978-10-26
BG27746A3 (bg) 1979-12-12
GB1575904A (en) 1980-10-01
RO72831A (fr) 1983-08-03
AU514822B2 (en) 1981-02-26
DE2717415A1 (de) 1977-11-10
ATA285177A (de) 1979-08-15
IE44730B1 (en) 1982-03-10
FR2348925A1 (fr) 1977-11-18
AR222003A1 (es) 1981-04-15
IL51787A0 (en) 1977-05-31
NO771398L (no) 1977-10-25
IE44730L (en) 1977-10-23

Similar Documents

Publication Publication Date Title
AU517514B2 (en) 3-de-0-methylfortimicins
AU2542577A (en) 4-amino-4-arylcyclohexanones
AU2384277A (en) Triazolo-pyrimidines
GB1542539A (en) Bicycle-trailer
CS164777A2 (en) Zpusob ziskavani krystalickeho xylitolu farmaceuricke jakosti
GB1522457A (en) Benzocycloheptafurans
AU2726877A (en) Benzofuranyl-benzimidazoles
AU3191677A (en) Cyclopentan-1-amine
AU507260B2 (en) N-2-imidazolidinylidene-benzeneamine
AU2451277A (en) Isothiazolopyridines
AU1309176A (en) Fire-barriers
JPS5351072A (en) Coocking instrumemts
GB1538366A (en) Pyridobenzodiazepines
BG23251A1 (en) Stabilograph
AU508067B2 (en) Electroradiography
AU2893177A (en) Perhydroindolinols
GB1520699A (en) Benzoxazolenes
AU2378777A (en) Amino - alkoxyalkanes
CY1158A (en) Arylmalonamido-1-oxadethiacephalosporins
GB1537670A (en) De-tinning
AU517716B2 (en) Carboxtryrils
AU507548B2 (en) Electron-radiography
AU2710877A (en) Benzodioxepins
AU2664077A (en) Frequency-synthesizer-tuner
NZ184636A (en) 16-methoxycarbonyl-16-hydroxyaspidospermidines